Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keira Capital Partners is a private Canadian financial advisory firm focused on mergers and acquisitions and equity and debt financing assignments. The firm advises private and publicly traded companies and acts as the Canadian exclusive representative of CDI Global, giving it access to an international network of independent investment banks and M&A firms. Keira serves multiple industries, including healthcare, but it is not itself a biotech, pharma, or healthcare operating company. Its services include sell-side and buy-side M&A advisory, financing support, and strategic transaction execution for mid-market clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keira Capital Partners.